Oxford, UK – 4 February 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces ...
Detailed price information for Oxford Biomedica Plc (OXBDF) from The Globe and Mail including charting and trades.
Upregulated expression of transcription factors promoting cone identity in late-stage retinal progenitors drives development ...
Odyssey’s Ai-Dual putters focus on more consistent roll and clearer aim, introducing a new insert design and the Half-Ball alignment option.
1don MSN
Dual-action molecule design concentrates cancer treatment in tumor cells to allow higher doses
Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more ...
Researchers at the School of Biological Sciences of The University of Hong Kong (HKU) have uncovered how eukaryotic cells can ...
The 4th Infantry Division is working to scale testing of the Army’s next-generation command-and-control system from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results